Pretreatment and Acquired Drug Resistance in Children With Human Immunodeficiency Virus Type 1 in Jos, Nigeria.
Augustine O EbonyiJonathan OkpokwuHolly E RawizzaPhilippe ChebuBeth ChaplinDonald HamelStephen OgucheOche O AgbajiAtiene S SagayPhyllis J KankiGodwin E ImadePublished in: Open forum infectious diseases (2024)
We determined pretreatment and acquired human immunodeficiency virus (HIV) drug resistance among children with HIV type 1 (HIV-1) in Jos, Nigeria. The majority (71%) of those who failed first-line antiretroviral therapy were on a nevirapine-containing regimen. The prevalence of pretreatment (48%) and acquired (76%) HIV drug resistance mutations was high in our study. Wider access to HIV drug resistance testing after treatment failure is necessary to optimize second-line treatment options among children with HIV in Nigeria.